Catalyst Biosciences Raises $40 Million
Catalyst Biosciences Inc., a South San Francisco-based developer of engineered proteases, has raised $40.4 million in Series C funding. Essex Woodlands Health Ventures led the round, and was joined by return backers Burrill & Co., HealthCare Ventures, Johnson & Johnson Development Corp., Morgenthaler Ventures, Novartis BioVentures and Sofinnova Ventures. The company had previously raised around $42 million.
4 December 2008•2 mins read
